Skip to main content

In commemoration of Huaxi Xu

It is with a heavy heart that Springer Nature and Molecular Neurodegeneration say farewell to our long-serving co-Editor-in-Chief, Dr. Huaxi Xu. On October 14, 2022, Dr. Xu passed away after his brave battle against cancer, leaving behind a legacy of groundbreaking research in neurodegenerative disease, exemplary editorship, and undeniable leadership.

In the seventeen years of publication, Dr. Xu and Dr. Bu have raised Molecular Neurodegeneration to be a leading open-access neuroscience journal. This page is in commemoration of Dr. Xu’s work, life, and legacy. We invite friends, family, editors, authors, and reviewers alike to leave any notes or pictures. Please email Molecular Neurodegeneration’s Associate Publisher, Anastasiya Netrunenko ( with your messages for and pictures with Huaxi.

Read More


Alzheimer's Disease: Challenges for the next decade

Neuron cell system shown in blue

Molecular Neurodegeneration presents a new thematic series, collating reviews which present and evaluate the challenges for the next decade of research into Alzheimer's disease. 

Edited by Guojun Bu, Alison Goate and Todd Golde. The collection can be read here.

Contact the Managing Editorial Team

Hongmei Li 

Lucy Job 

About Us

The leading open access journal in the field of neurosciences, Molecular Neurodegeneration encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

Read more

Article collections

ALS: Challenges and New Advances

Alzheimer's Disease: Challenges for the next decade

Parkinson's Disease - A Series of Reviews
Novel Systems and Emerging Concepts
Basic biology and disease pathways

Official journal of

Annual Journal Metrics